Pharmaceutical And Biotech Cooling Requirements: What Sets Them Apart August 4, 2026 Pharmaceutical and biotechnology manufacturing operates under regulatory requirements that fundamentally shape cooling system design. Temperature control failures in pharma and biotech don't just affect product quality — they can invalidate entire batches, trigger regulatory action, and in the case of biologics and vaccines, create patient safety concerns. The cooling infrastructure in these environments is subject to design, documentation, and validation requirements not found in other industries. How Pharma Cooling Differs from Standard Industrial Cooling Several characteristics distinguish pharmaceutical cooling from conventional industrial process cooling: cGMP compliance: current Good Manufacturing Practice regulations (FDA 21 CFR Parts 210/211 for pharmaceuticals; Part 820 for devices) establish requirements for equipment design, documentation, and maintenance that apply to cooling systems serving manufacturing processes Validation: cooling systems serving direct product contact areas or critical manufacturing processes must be qualified — Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) demonstrate that the system was installed correctly, operates as intended, and delivers defined performance consistently Cleanroom compatibility: cooling equipment serving cleanroom environments must not generate particles, must not use coolants that could contaminate the manufacturing environment, and must maintain cleanroom pressure differentials Documentation and traceability: temperature monitoring records, maintenance logs, and calibration records must be maintained and available for regulatory inspection "Pharmaceutical cooling systems are not just process utilities — they're part of the quality system. Design decisions made early in a project have compliance implications that are expensive to fix after installation."— Paul Johnson, G&D Chillers Key Cooling Applications in Pharma and Biotech Application Cooling Requirement Bioreactor temperature control Precise temperature control (+/- 0.5-1 degree C) during cell culture; critical to product yield and quality attributes Fermentation cooling Pharmaceutical fermentation (API production) requires tight temperature during reaction phases Lyophilization (freeze drying) Product is frozen to -40 to -50 degrees C and shelf temperature precisely controlled during primary and secondary drying Cold storage (API, finished goods) 2-8 degrees C refrigeration; temperature excursion monitoring and alarming required Ultra-cold storage (vaccines, cell therapy) Down to -80 degrees C for some biologics; cryogenic storage for cell and gene therapies HVAC for classified spaces Clean room HVAC systems require precise temperature and humidity control; validated and commissioned Qualification and Documentation Requirements Process cooling systems serving pharmaceutical manufacturing must be qualified if they affect product quality: IQ: documents that installed equipment matches approved design specifications OQ: demonstrates that the system operates within defined parameters under all specified operating conditions PQ: demonstrates consistent performance under actual production conditions over time Change control: modifications to qualified systems trigger formal change control review to assess impact on qualification status Frequently Asked Questions Does every cooling system in a pharma facility require validation? No — only systems that directly affect product quality require formal qualification. Utility cooling systems serving non-product-contact areas (comfort cooling, equipment cooling that doesn't directly contact API or finished product) typically require documented preventive maintenance programs but not formal IQ/OQ/PQ validation. What coolants are acceptable in pharmaceutical environments? For systems that could potentially contact product, USP-grade or food-grade glycols are required. Systems fully separated from product contact areas can use standard industrial glycol, but documentation of the separation and containment must be maintained. > Work with G&D's team on cooling for pharmaceutical and biotech facilities -> Contact us